Instem is proud to be a gold sponsor at the 60th EUROTOX Congress once again this year.
Visit us at Booth 23 to discover our industry-leading solutions for preclinical study management, regulatory compliance, predictive toxicology, in silico modelling, and data-driven insights. Our team will be on hand throughout the event to discuss how we can help accelerate your research and support your scientific and regulatory goals.
Presentations & Posters
Industry Hosted Session – Data a Regulator Can Act On: NAMs-Ready Infrastructure for ADME and Early Safety
Regulatory agencies across the Atlantic now require context-of-use validation for integrating New Approach Methodologies (NAMs) with traditional animal models. While the science is established, the infrastructure isn’t. NAMs data differs fundamentally from traditional study data: it’s multi-endpoint, multi-modal, decision-critical, and evaluated at project level, demanding new systems architecture. This session presents a practical framework for NAMs-ready infrastructure covering assay standardisation, structured endpoint capture, cross-study comparability, and regulatory compliance. Using Instem’s BioRails platform as an example, it demonstrates how to ingest diverse NAM data, normalise it, and deliver regulator-ready packages in formats reviewers already understand. Attendees will learn to assess their systems against integrated, context-of-use-driven requirements and align teams on implementation gaps.
Presented by Szczepan Baran, CSO | Tuesday, 15 September | 12:15–13:15 | Room 0.16, Level 0
Poster Presentation – An Integrated Framework for Supporting Read-Across Assessments in Chemical Safety
The poster presents a detailed case study focusing on extractables and leachables exceeding systemic toxicity qualification thresholds under emerging regulatory guidance (ICH Q3E). The case study and overall framework illustrate how a unified, software-supported framework integrating cheminformatics, toxicological data, and structured expert input can support transparency, consistency, and scientific confidence in read‑across based safety assessment. This framework can be applied across a broad range of substance classes, regulatory contexts, and product domains.
Presented by Mahmoud Ahmed, Research Data Scientist | Monday, 14 September | Visit Poster P18-120 during Poster Viewing 1 (PV01)
Learn more about our leading software & services, including:
Provantis®
Streamlines end-to-end workflows for preclinical study management. Ask about our new Non-GLP Pathology module!
Logbook™
An electronic laboratory notebook (ELN) that simplifies and streamlines the digitization and documentation of lab processes.
SEND Advantage™ Outsourced Services and Consulting
A suite of services that ensure your nonclinical data meets the Standard for Exchange of Nonclinical Data (SEND) submission requirements.
Submit™ Seamless Electronic SEND Submissions
Improves the speed and quality of new pharmaceutical developments by enabling the efficient exchange of critical study data between sponsors, CROs and regulators.
Cyto Study Manager™
Enables improved management of genotoxicity studies, delivering enhanced accuracy, documentation and compliance.
Leadscope Model Applier™
An advanced In Silico toxicology tool that helps scientists predict toxicity endpoints, review results with confidence, and generate regulatory-compliant reports. Ask the team for a demo of our new Toxicity Profiler!
KnowledgeScan™
Technology-enabled Target Safety Assessment service enabling researchers to make smarter, faster, data driven decisions.
Centrus®
This powerful tool consolidates and structures data from various sources into a unified, accessible platform, enabling high-quality data management and seamless data sharing for early-stage research.
Advance™
A comprehensive solution supporting the ICH S1B Weight of Evidence Addendum for assessing carcinogenicity risk. Advance streamlines early-stage safety evaluations, reducing costs, saving valuable time, and minimizing the need for animal testing.
Predict™
Our Predict service uses advanced QSAR techniques to streamline early-stage safety assessments through predictive modeling. Enables researchers to evaluate potential toxicity risks quickly, supporting data-driven decision-making and reducing the need for subject testing.
Want to talk in more detail? Contact us to schedule a 1:1 meeting. We look forward to seeing you there!
For more information, visit the Event Website
